Emergingby GlyphShift Bioscience reports single-gene target for safer cell rejuvenation
SB000 reversed cellular aging across cell types without triggering pluripotency pathways.
Longevity biotechshiftbioscience.com
Shift Bioscience
StartupGB1 field
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechUses an AI virtual cell platform and aging clocks to find single-gene targets for safer cell rejuvenation. | Uses an AI virtual cell platform and aging clocks to find single-gene targets for safer cell rejuvenation. | shiftbioscience.com |
Events
Funding
$16M
Led by BGF
About
- Source
- shiftbioscience.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Oct 6, 2026
- Across Glyph
- Shift Bioscience on Companies
Shift Bioscience
Joined in Longevity biotech. Uses an AI virtual cell platform and aging clocks to find single-gene targets for safer cell rejuvenation.
Shift Bioscience
Added in Longevity biotech. Uses an AI virtual cell platform and aging clocks to find single-gene targets for safer cell rejuvenation.